Loading...
Biotage AB (publ)
BITGF•PNK
Healthcare
Medical - Instruments & Supplies
$15.01
$0.00(0.00%)
Biotage AB (publ) (BITGF) Financial Performance & Income Statement Overview
Analyze Biotage AB (publ) (BITGF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
10.42%
↑ 10.42%
Operating Income Growth
1.86%
↑ 1.86%
Net Income Growth
15.45%
↑ 15.45%
Operating Cash Flow Growth
45.42%
↑ 45.42%
Operating Margin
15.68%
↑ 15.68%
Gross Margin
62.18%
↑ 62.18%
Net Profit Margin
11.43%
↑ 11.43%
ROE
5.67%
↑ 5.67%
ROIC
5.57%
↑ 5.57%
Biotage AB (publ) (BITGF) Income Statement & Financial Overview
Analyze Biotage AB (publ)’s BITGF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $385.00M | $582.00M | $490.00M | $504.00M |
| Cost of Revenue | $143.00M | $222.00M | $187.00M | $180.00M |
| Gross Profit | $242.00M | $360.00M | $303.00M | $324.00M |
| Gross Profit Ratio | $0.63 | $0.62 | $0.62 | $0.64 |
| R&D Expenses | $43.00M | $51.00M | $41.00M | $45.00M |
| SG&A Expenses | $203.00M | $202.00M | $194.00M | $195.00M |
| Operating Expenses | $254.00M | $185.00M | $238.00M | $240.00M |
| Total Costs & Expenses | $397.00M | $407.00M | $425.00M | $420.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $4.00M | $9.00M |
| Depreciation & Amortization | $40.00M | $47.00M | $46.00M | $46.00M |
| EBITDA | $28.00M | $222.00M | $111.00M | $130.00M |
| EBITDA Ratio | $0.07 | $0.38 | $0.23 | $0.26 |
| Operating Income | -$12.00M | $175.00M | $65.00M | $84.00M |
| Operating Income Ratio | -$0.03 | $0.30 | $0.13 | $0.17 |
| Other Income/Expenses (Net) | $16.00M | -$17.00M | -$4.00M | -$9.00M |
| Income Before Tax | $4.00M | $158.00M | $61.00M | $68.00M |
| Income Before Tax Ratio | $0.01 | $0.27 | $0.12 | $0.13 |
| Income Tax Expense | $0.00 | -$1.00M | $16.00M | $20.00M |
| Net Income | $4.00M | $159.00M | $45.00M | $48.00M |
| Net Income Ratio | $0.01 | $0.27 | $0.09 | $0.10 |
| EPS | $0.05 | $1.99 | $0.56 | $0.60 |
| Diluted EPS | $0.05 | $1.98 | $0.56 | $0.60 |
| Weighted Avg Shares Outstanding | $80.05M | $80.05M | $80.05M | $80.008M |
| Weighted Avg Shares Outstanding (Diluted) | $80.18M | $80.17M | $80.11M | $80.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan